There is presently a substantial amount of information being gathered concerning the environmental risk associated with the perfluorooctane sulfonate (PFOS) compound. The U.S. Environmental Protection Agency (U.S. EPA) is requiring that more research be completed before making definitive decisions concerning the regulatory issues covered in the significant new use rule (18/10-2000) under the Toxic Substance Control Act. However, there are no risk assessment requirements under seminatural conditions in microcosms. The PFOS can enter, and has been found in, the aquatic environment through different pathways, including spills associated with use of fire-fighting foams containing PFOS, leaching from washing Scotchgard-treated clothes with the wastewater, leaching from various coatings, discharges as residual waste from fluorochemical production, or volatilization and transportation atmospherically. The biota is the sink of PFOS rather than the sediment or soil. The aim of this article is to determine a 35-d community no-observable-effect concentration (NOECcommunity) for freshwater zooplankton and the fate of PFOS during the course of study. The PFOS persisted in the water phase with only slight reductions over the study; only the decrease from 33.9 mg/L at day 1 to 29.8 mg/L at day 35 was significant. A 90 to 100% reduction (p < 0.01) of the total zooplankton population was found after one week of exposure to 30 mg PFOS/L and a similar reduction after two weeks at 10 mg PFOS/L. The Daphnia magna 21-d NOECsurvival of 12 mg/L has previously been found in a standard laboratory bioassay by 3M. The rank order of susceptibility for the test community was Copepoda > Cladocera > Rotifera, assuming all adverse direct effects.
No takes yet. Share an insight, caveat, or question.
Sanderson et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: